Bill Text: TX HR435 | 2023-2024 | 88th Legislature | Comm Sub
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Urging the Texas Department of State Health Services and the Texas Health and Human Services Commission to expand their comprehensive cardiovascular screening programs.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2023-05-12 - Reported enrolled [HR435 Detail]
Download: Texas-2023-HR435-Comm_Sub.html
Bill Title: Urging the Texas Department of State Health Services and the Texas Health and Human Services Commission to expand their comprehensive cardiovascular screening programs.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Passed) 2023-05-12 - Reported enrolled [HR435 Detail]
Download: Texas-2023-HR435-Comm_Sub.html
88R14725 TBO-D | ||
By: Raymond | H.R. No. 435 |
|
||
WHEREAS, Cardiovascular disease is the leading cause of death | ||
in the United States, and approximately 21 million U.S. patients | ||
have been diagnosed with atherosclerotic cardiovascular disease, | ||
indicating that they are at risk of a cardiovascular event; and | ||
WHEREAS, In Texas, health care professionals have diagnosed | ||
angina, strokes, heart attacks, or coronary heart diseases for more | ||
than 1,790,000 adults, and these conditions have been identified as | ||
manifestations of atherosclerotic cardiovascular disease; in | ||
addition, over 864,000 adult Texans have reported experiencing a | ||
heart attack in their lifetime, and more than 798,000 have reported | ||
experiencing a stroke; the heart disease death rate in Texas is 328 | ||
deaths per 100,000 individuals over the age of 35, surpassing the | ||
national rate of 319.5; and | ||
WHEREAS, Research shows that atherosclerotic cardiovascular | ||
disease is linked to the buildup of cholesterol in the arteries, and | ||
the risk of cardiovascular events can be reduced by decreasing | ||
low-density lipoprotein cholesterol (LDL-C) levels; nearly 70 | ||
million U.S. adults had higher than recommended LDL-C levels in | ||
2016, and more than 43 million U.S. residents are currently being | ||
treated with lipid-lowering therapies to manage cardiovascular | ||
risk; statins are one of the leading lipid-lowering therapies, and | ||
20 percent of atherosclerotic cardiovascular disease patients | ||
taking statins have achieved healthy levels of LDL-C; and | ||
WHEREAS, The total direct and indirect cost of | ||
atherosclerotic cardiovascular disease in the U.S. was $555 billion | ||
in 2016, and the cost is projected to reach $1.1 trillion by 2035; | ||
each year, the State of Texas spends an estimated $10.53 billion on | ||
direct medical expenses for health care related to atherosclerotic | ||
cardiovascular disease; and | ||
WHEREAS, Cardiovascular diseases impact the lives of | ||
countless residents across the state, and it is vital that these | ||
Texans have access to quality health care; now, therefore, be it | ||
RESOLVED, That the House of Representatives of the 88th Texas | ||
Legislature hereby urge the Texas Department of State Health | ||
Services and the Texas Health and Human Services Commission to | ||
expand their comprehensive cardiovascular screening programs and | ||
explore ways to collaborate with federal and national agencies and | ||
organizations to establish or expand cardiovascular screening | ||
programs; and, be it further | ||
RESOLVED, That the Texas cardiovascular plan should be | ||
updated to enhance the quality of care rendered to patients and | ||
improve health outcomes; and, be it further | ||
RESOLVED, That the House of Representatives of the 88th Texas | ||
Legislature hereby express support for the creation of policies to | ||
lower the rates of death caused by atherosclerotic cardiovascular | ||
disease; and, be it further | ||
RESOLVED, That the chief clerk of the Texas House of | ||
Representatives forward an official copy of this resolution to the | ||
commissioners of the Texas Department of State Health Services and | ||
the Texas Health and Human Services Commission. |